• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含渗透增强剂的囊泡:结构特征和皮肤渗透能力的组成依赖性。

Penetration enhancer-containing vesicles: composition dependence of structural features and skin penetration ability.

机构信息

Dept. Scienze della Vita e dell'Ambiente, Sezione Scienzedel Farmaco, University of Cagliari, CNBS, via Ospedale 72, Cagliari, Italy.

出版信息

Eur J Pharm Biopharm. 2012 Oct;82(2):352-9. doi: 10.1016/j.ejpb.2012.06.015. Epub 2012 Aug 13.

DOI:10.1016/j.ejpb.2012.06.015
PMID:22922162
Abstract

In this work, we focused on how composition and preparation method of vesicles might affect their morphological features and delivery performances. Penetration Enhancer-containing Vesicles, PEVs, vesicles containing a water miscible penetration enhancer (Transcutol® P; 10%, 20%, 30% v/v) and encapsulating diclofenac sodium, were formulated and compared with conventional liposomes. A cheap and unpurified commercial mixture of phospholipids, fatty acids, and triglycerides (Phospholipon® 50) was used, and the effects of this heterogeneous composition (along with the presence or absence of transcutol and the production method) on vesicle morphology, size, surface charge, drug loading, and stability were investigated. The variations in vesicle structure, bilayer thickness, and number of lamellae were assessed by TEM and Small and Wide Angle X-ray Scattering, which also proved the liquid state of the vesicular bilayer. Further, vesicles were evaluated for ex vivo (trans)dermal delivery, and their mode of action was studied performing a pre-treatment test and confocal laser scanning microscopy analyses. Results showed the formation of multi- and unilamellar vesicles that provided improved diclofenac delivery to pig skin, influenced by vesicle lipid composition and structure. Images of the qualitative CLSM analyses support the conclusion that PEVs enhance drug transport by penetrating intact the stratum corneum, thanks to a synergic effect of vesicles and penetration enhancer.

摘要

在这项工作中,我们专注于囊泡的组成和制备方法如何影响其形态特征和传递性能。载药囊泡(PEV)是指含有水混溶性渗透增强剂(Transcutol® P;10%、20%、30%v/v)并包载双氯芬酸钠的囊泡,与传统脂质体进行了比较。我们使用了一种廉价且未纯化的商业混合物磷脂、脂肪酸和甘油三酯(Phospholipon® 50),并研究了这种不均匀组成(以及是否存在 Transcutol 和生产方法)对囊泡形态、大小、表面电荷、载药量和稳定性的影响。TEM 和小角和广角 X 射线散射评估了囊泡结构、双层厚度和层片数的变化,这也证明了囊泡双层的液态。此外,还评估了囊泡用于离体(透皮)给药的性能,并通过预处理试验和共聚焦激光扫描显微镜分析研究了其作用模式。结果表明,形成了多和单室囊泡,这改善了双氯芬酸钠向猪皮的传递,这受到囊泡脂质组成和结构的影响。定性 CLSM 分析的图像支持这样的结论,即载药囊泡通过协同作用增强药物穿透完整的角质层来增强药物输送。

相似文献

1
Penetration enhancer-containing vesicles: composition dependence of structural features and skin penetration ability.含渗透增强剂的囊泡:结构特征和皮肤渗透能力的组成依赖性。
Eur J Pharm Biopharm. 2012 Oct;82(2):352-9. doi: 10.1016/j.ejpb.2012.06.015. Epub 2012 Aug 13.
2
Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction.经皮递送双氯芬酸的透皮醇含药脂质体及其与皮肤相互作用的机制探讨。
Eur J Pharm Biopharm. 2011 May;78(1):27-35. doi: 10.1016/j.ejpb.2010.12.010. Epub 2010 Dec 15.
3
Close-packed vesicles for diclofenac skin delivery and fibroblast targeting.紧密堆积的囊泡用于双氯芬酸皮肤传递和成纤维细胞靶向。
Colloids Surf B Biointerfaces. 2013 Nov 1;111:609-17. doi: 10.1016/j.colsurfb.2013.07.014. Epub 2013 Jul 12.
4
Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs.囊泡载体(脂质体、醇质体和 PEV)中双氯芬酸抑制小鼠皮肤炎症。
Int J Pharm. 2013 Feb 25;443(1-2):128-36. doi: 10.1016/j.ijpharm.2012.12.041. Epub 2013 Jan 5.
5
Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.含渗透促进剂的囊泡(PEV)作为米诺地尔经皮递送的载体。
Int J Pharm. 2009 Oct 1;380(1-2):72-9. doi: 10.1016/j.ijpharm.2009.06.040. Epub 2009 Jul 7.
6
Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin.含有囊泡的透皮促进剂作为维 A 酸经皮给药的载体。
Int J Pharm. 2011 Jun 30;412(1-2):37-46. doi: 10.1016/j.ijpharm.2011.03.068. Epub 2011 Apr 16.
7
Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: in vitro evaluation of drug permeation by infrared spectroscopy.含渗透促进剂的囊泡(PEVs)作为米诺地尔经皮传递的载体:红外光谱法评估药物渗透的体外研究。
Pharm Dev Technol. 2013 Nov-Dec;18(6):1339-45. doi: 10.3109/10837450.2012.685661. Epub 2012 May 8.
8
Transcutol containing vesicles for topical delivery of minoxidil.含有 Transcutol 的微囊用于米诺地尔的经皮给药。
J Drug Target. 2011 Apr;19(3):189-96. doi: 10.3109/1061186X.2010.483516. Epub 2010 May 6.
9
Penetration Enhancer-Containing Vesicles: Does the Penetration Enhancer Structure Affect Topical Drug Delivery?含渗透促进剂的囊泡:渗透促进剂结构会影响局部给药吗?
Curr Drug Targets. 2015;16(13):1438-47. doi: 10.2174/1389450115666140804224024.
10
Skin penetration behaviour of liposomes as a function of their composition.脂质体作为其组成的函数的皮肤渗透行为。
Eur J Pharm Biopharm. 2011 Sep;79(1):43-53. doi: 10.1016/j.ejpb.2011.01.011. Epub 2011 Jan 24.

引用本文的文献

1
Vitamin D-loaded lipid nanoparticles: antioxidant properties, preparation, optimization, and in vitro characterization.负载维生素D的脂质纳米颗粒:抗氧化特性、制备、优化及体外表征
Drug Deliv Transl Res. 2025 Aug 23. doi: 10.1007/s13346-025-01946-1.
2
Skin penetration enhancers: Mechanistic understanding and their selection for formulation and design.皮肤渗透促进剂:作用机制的理解及其在制剂和设计中的选择
Drug Deliv Transl Res. 2025 Feb 21. doi: 10.1007/s13346-025-01809-9.
3
Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?
我们准备好测量脂质体包裹的现代抗衰GHK-Cu三肽的皮肤渗透性了吗?
Molecules. 2025 Jan 1;30(1):136. doi: 10.3390/molecules30010136.
4
Skin Penetration and Permeation Properties of Transcutol in Complex Formulations.复杂制剂中环己醇的经皮渗透和渗透特性。
AAPS PharmSciTech. 2024 Sep 5;25(7):201. doi: 10.1208/s12249-024-02886-8.
5
Glucospanlastics: innovative antioxidant and anticancer ascorbyl-2-glucoside vesicles for striking topical performance of repurposed itraconazole.葡糖弹性体:创新的抗氧化剂和抗癌抗坏血酸-2-葡糖苷囊泡,用于显著提升重新利用的伊曲康唑的局部性能。
RSC Adv. 2024 Aug 22;14(36):26524-26543. doi: 10.1039/d4ra03542a. eCollection 2024 Aug 16.
6
Using a Topical Formulation of Vitamin D for the Treatment of Vitiligo: A Systematic Review.采用局部用维生素 D 制剂治疗白癜风:系统评价。
Cells. 2023 Sep 30;12(19):2387. doi: 10.3390/cells12192387.
7
Decrypting the Potential of Nanotechnology-Based Approaches as Cutting-Edge for Management of Hyperpigmentation Disorder.解析纳米技术为基础的方法在治疗色素沉着障碍方面的潜在应用
Molecules. 2022 Dec 26;28(1):220. doi: 10.3390/molecules28010220.
8
Management and control of intraocular pressure applying macitentan hydrogel film formulation: improved effect of surfactant and cosurfactant system.应用麦考酚钠水凝胶膜制剂管理和控制眼内压:表面活性剂和助表面活性剂体系的改善效果。
Daru. 2022 Jun;30(1):39-47. doi: 10.1007/s40199-021-00428-2. Epub 2022 Jan 7.
9
In Vitro Skin Permeation of Idebenone from Lipid Nanoparticles Containing Chemical Penetration Enhancers.艾地苯醌从含有化学渗透促进剂的脂质纳米粒的体外皮肤渗透
Pharmaceutics. 2021 Jul 6;13(7):1027. doi: 10.3390/pharmaceutics13071027.
10
Importance of the formulation in the skin delivery of topical diclofenac: not all topical diclofenac formulations are the same.剂型在双氯芬酸经皮给药中的重要性:并非所有双氯芬酸局部用制剂都相同。
J Pain Res. 2019 Apr 12;12:1149-1154. doi: 10.2147/JPR.S191300. eCollection 2019.